Probiotics Market Size, Demand, Analytical Overview, Comprehensive Analysis, Segmentation, Competitive Landscape 2035
Probiotics Market: Market Landscape
The global probiotics market size is estimated to be $70.9 billion in 2024 and is projected to reach $165.1 billion by 2035. The market is anticipated to grow at a CAGR of 8.0%, during the forecast period till 2035.
The current market landscape features over 95 key probiotic companies that are engaged in offering probiotics. Several key companies (established as well as start-ups) in the probiotic domain offer various types of products, including probiotic foods, beverages, dietary supplements and infant formula. Notable examples of mid-sized probiotic companies based in Europe (in alphabetical order) include AB-BIOTICS, BioGaia, Enzymedica, Myprotein, PetLab and Zinereo Pharma. Interestingly, the end users of probiotic industry are children, infants, humans and animals. Various types of novel strains are being studied by the industry in order to identify its usage as a probiotic. These formulations can be used in foods, beverages, formulaes and supplements.
Most of the key probiotic companies were established pre-2000, depticting that the probiotics industry consists of some well-established players that have a strong customer base. Some examples of such probiotic companies include (in alphabetical order) adisseo, Bharat Biotech, Danone, IFF, Morinaga Milk, NowFoods, Tata, Yakult Honsha and Zipvit.
Majority of the key players (75%) offer probiotic dietary supplements; of these, more than 90% companies offer both nutritional as well as specialty supplements that support specific health conditions, such as mental, oral, bone, immune and women health. Apart from offering various types of probiotics for the human population, the key probiotic companies are also extensively engaged in offering probiotics for infants and children, whose microbiome is different and thus require different combinations of strains in the probiotic products.
More than 500 patents related to probiotics have been filed / granted by the probiotic providers in order to protect the intellectual property generated within this field.
Over the past decade, industry stakeholders have been extensively working towards the development of novel probiotic formulations and products. Recently, the domain has witnessed significant advancements, both in terms of introduction of novel probiotics to support overall well-being and specific health conditions. As a result, a number of patents have been filed / granted to protect the new intellectual capital generated by the probiotic companies engaged in offering various types of probiotics.
During our research, it was observed that majority of the patents filed by probiotic companies in this domain are patent applications (73.6%), followed by those which have been granted approval (26%). Further, majority of the patents (39%) were filed / granted in North America, followed by Asia Pacific (27%). Moreover, despite the large number of patents that have been filed by probiotic companies recently (and hence having a long remaining patent life), only 2% of the total patents have the highest relative valuation.
Using our proprietary methodology, we have provided informed projections, describing the likely growth of the opportunity associated with the probiotics market. As per the base case forecast scenario, the probiotic market size is estimated to grow at a CAGR of 8.0%, during the forecast period. The market growth of this industry is believed to be primarily driven by the numerous advantages offered by probiotics for prevention and treatment of diseases. This is anticipated to sustain the demand for various types of probiotics, resulting in lucrative monetization opportunities for probiotic companies.
It is worth mentioning that according to our projections, Asia Pacific is likely to capture the majority (more than 45%) of the overall market share, and this trend is unlikely to change in the future, as well. It is worth highlighting that the global market in Latin America is expected to grow at a relatively healthy CAGR, during the forecast period. Further, it is worth mentioning that, as per the probiotics market segmentation, probiotic dietary supplements segment in the probiotics market is anticipated to grow at a higher CAGR, during the forecast period.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/probiotics-market.html
Probiotics Market: Market Landscape
The global probiotics market size is estimated to be $70.9 billion in 2024 and is projected to reach $165.1 billion by 2035. The market is anticipated to grow at a CAGR of 8.0%, during the forecast period till 2035.
The current market landscape features over 95 key probiotic companies that are engaged in offering probiotics. Several key companies (established as well as start-ups) in the probiotic domain offer various types of products, including probiotic foods, beverages, dietary supplements and infant formula. Notable examples of mid-sized probiotic companies based in Europe (in alphabetical order) include AB-BIOTICS, BioGaia, Enzymedica, Myprotein, PetLab and Zinereo Pharma. Interestingly, the end users of probiotic industry are children, infants, humans and animals. Various types of novel strains are being studied by the industry in order to identify its usage as a probiotic. These formulations can be used in foods, beverages, formulaes and supplements.
Most of the key probiotic companies were established pre-2000, depticting that the probiotics industry consists of some well-established players that have a strong customer base. Some examples of such probiotic companies include (in alphabetical order) adisseo, Bharat Biotech, Danone, IFF, Morinaga Milk, NowFoods, Tata, Yakult Honsha and Zipvit.
Majority of the key players (75%) offer probiotic dietary supplements; of these, more than 90% companies offer both nutritional as well as specialty supplements that support specific health conditions, such as mental, oral, bone, immune and women health. Apart from offering various types of probiotics for the human population, the key probiotic companies are also extensively engaged in offering probiotics for infants and children, whose microbiome is different and thus require different combinations of strains in the probiotic products.
More than 500 patents related to probiotics have been filed / granted by the probiotic providers in order to protect the intellectual property generated within this field.
Over the past decade, industry stakeholders have been extensively working towards the development of novel probiotic formulations and products. Recently, the domain has witnessed significant advancements, both in terms of introduction of novel probiotics to support overall well-being and specific health conditions. As a result, a number of patents have been filed / granted to protect the new intellectual capital generated by the probiotic companies engaged in offering various types of probiotics.
During our research, it was observed that majority of the patents filed by probiotic companies in this domain are patent applications (73.6%), followed by those which have been granted approval (26%). Further, majority of the patents (39%) were filed / granted in North America, followed by Asia Pacific (27%). Moreover, despite the large number of patents that have been filed by probiotic companies recently (and hence having a long remaining patent life), only 2% of the total patents have the highest relative valuation.
Using our proprietary methodology, we have provided informed projections, describing the likely growth of the opportunity associated with the probiotics market. As per the base case forecast scenario, the probiotic market size is estimated to grow at a CAGR of 8.0%, during the forecast period. The market growth of this industry is believed to be primarily driven by the numerous advantages offered by probiotics for prevention and treatment of diseases. This is anticipated to sustain the demand for various types of probiotics, resulting in lucrative monetization opportunities for probiotic companies.
It is worth mentioning that according to our projections, Asia Pacific is likely to capture the majority (more than 45%) of the overall market share, and this trend is unlikely to change in the future, as well. It is worth highlighting that the global market in Latin America is expected to grow at a relatively healthy CAGR, during the forecast period. Further, it is worth mentioning that, as per the probiotics market segmentation, probiotic dietary supplements segment in the probiotics market is anticipated to grow at a higher CAGR, during the forecast period.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/probiotics-market.html
Probiotics Market Size, Demand, Analytical Overview, Comprehensive Analysis, Segmentation, Competitive Landscape 2035
Probiotics Market: Market Landscape
The global probiotics market size is estimated to be $70.9 billion in 2024 and is projected to reach $165.1 billion by 2035. The market is anticipated to grow at a CAGR of 8.0%, during the forecast period till 2035.
The current market landscape features over 95 key probiotic companies that are engaged in offering probiotics. Several key companies (established as well as start-ups) in the probiotic domain offer various types of products, including probiotic foods, beverages, dietary supplements and infant formula. Notable examples of mid-sized probiotic companies based in Europe (in alphabetical order) include AB-BIOTICS, BioGaia, Enzymedica, Myprotein, PetLab and Zinereo Pharma. Interestingly, the end users of probiotic industry are children, infants, humans and animals. Various types of novel strains are being studied by the industry in order to identify its usage as a probiotic. These formulations can be used in foods, beverages, formulaes and supplements.
Most of the key probiotic companies were established pre-2000, depticting that the probiotics industry consists of some well-established players that have a strong customer base. Some examples of such probiotic companies include (in alphabetical order) adisseo, Bharat Biotech, Danone, IFF, Morinaga Milk, NowFoods, Tata, Yakult Honsha and Zipvit.
Majority of the key players (75%) offer probiotic dietary supplements; of these, more than 90% companies offer both nutritional as well as specialty supplements that support specific health conditions, such as mental, oral, bone, immune and women health. Apart from offering various types of probiotics for the human population, the key probiotic companies are also extensively engaged in offering probiotics for infants and children, whose microbiome is different and thus require different combinations of strains in the probiotic products.
More than 500 patents related to probiotics have been filed / granted by the probiotic providers in order to protect the intellectual property generated within this field.
Over the past decade, industry stakeholders have been extensively working towards the development of novel probiotic formulations and products. Recently, the domain has witnessed significant advancements, both in terms of introduction of novel probiotics to support overall well-being and specific health conditions. As a result, a number of patents have been filed / granted to protect the new intellectual capital generated by the probiotic companies engaged in offering various types of probiotics.
During our research, it was observed that majority of the patents filed by probiotic companies in this domain are patent applications (73.6%), followed by those which have been granted approval (26%). Further, majority of the patents (39%) were filed / granted in North America, followed by Asia Pacific (27%). Moreover, despite the large number of patents that have been filed by probiotic companies recently (and hence having a long remaining patent life), only 2% of the total patents have the highest relative valuation.
Using our proprietary methodology, we have provided informed projections, describing the likely growth of the opportunity associated with the probiotics market. As per the base case forecast scenario, the probiotic market size is estimated to grow at a CAGR of 8.0%, during the forecast period. The market growth of this industry is believed to be primarily driven by the numerous advantages offered by probiotics for prevention and treatment of diseases. This is anticipated to sustain the demand for various types of probiotics, resulting in lucrative monetization opportunities for probiotic companies.
It is worth mentioning that according to our projections, Asia Pacific is likely to capture the majority (more than 45%) of the overall market share, and this trend is unlikely to change in the future, as well. It is worth highlighting that the global market in Latin America is expected to grow at a relatively healthy CAGR, during the forecast period. Further, it is worth mentioning that, as per the probiotics market segmentation, probiotic dietary supplements segment in the probiotics market is anticipated to grow at a higher CAGR, during the forecast period.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/probiotics-market.html
0 Yorumlar
0 hisse senetleri
581 Views
0 önizleme
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek